Pharmacists can help address the significant asthma health disparities among racial, ethnic, and socioeconomic groups to help improve outcomes.
CagriSema is a subcutaneous injectable combination of cagrilintide and semaglutide that is currently in phase 3 trials.
Pharmacists will play a significant role in TKI adherence rates among patients.
Community pharmacists are uniquely positioned to assist with diabetes management using CGM devices.
CGM enhances diabetes management in pregnancy, improving outcomes.
Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
With the vast number of drugs that can induce photosensitivity, patients taking any of these medications should receive safety counseling, especially during the summer months.
Antimicrobial stewardship efforts focusing on accurate penicillin allergy histories, β-lactam cross-reactivity education, and guideline-driven narrow-spectrum prescribing may help sustainably decrease health care–associated Clostridioides difficile infection rates.
Pharmacists will play a significant role in TKI adherence rates among patients.
Interested individuals may gain certification or continuing-education credits, many of which are available through the American College of Veterinary Pharmacists.
Data have shown the potential for the therapy to treat several new conditions.
Understanding differences in the various levodopa formulations and assisting with medication therapy management is a crucial role for pharmacists.
BRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.
Pharmacists are an important part of the care team for patients with bleeding disorders, providing services such as medication counseling and reconciliation.
A collaborative exercise with 16 health care organizations nets millions in savings.
Pharmacists should be aware of current discussions, attempted fixes, and expected length of drug shortages.
Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
The Covid-19 pandemic has elevated telehealth as a viable alternative to face-to-face interactions under certain circumstances, the list of which is expanding as technology expands and clinicians become more accustomed to and adept in its use.
Tapping techs as immunizers opens up greater visibility and new source of health care labor.
A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
The incidence of vancomycin-resistant enterococci has nearly doubled in recent years.
COVID-19 has increased the demand for new, safer curbside conveniences and the health care industry—including the pharmacy—has transformed rapidly to meet patient needs and prioritize safety as a result of the pandemic.
Pharmacists can help address nicotine addiction by recommending FDA-approved smoking cessation methods and educating on the risks associated with electronic cigarette use.
Drs Anthony Perissinotti and Kirollos Hanna provide some important considerations for pharmacists in treating chronic lymphocytic leukemia.
Schizophrenia is a chronic mental illness that significantly affects patients through its symptoms, associated health conditions, and treatment challenges, with long-acting injectable antipsychotics offering potential benefits in improving adherence and reducing relapses.
Pharmacists ensure responsible antibiotic use, combating resistance through tailored therapies.
Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have transformed the treatment of hormone receptor-positive/HER2-negative breast cancer across metastatic and early-stage settings, with ongoing research exploring their potential in additional breast cancer subtypes, combination therapies, and aggressive disease scenarios.
Erin Harrell, PharmD, offers insights about managing peripheral neuropathy in patients receiving bortezomib.
As pharmacy practice continues to evolve, it is imperative to recognize the vital contributions of all members of the pharmacy team, including pharmacy technicians.